Lisa is a stock analyst with nearly 25 years of investment research experience. She earned a MBA in Finance from the University of Chicago in 1987 and began her career in investment research that same year as part of the equity research team at Kemper Financial Services. In 1989, Lisa joined the Financial Relations Board, a large investor relations consulting firm, rising to the position of director of financial analysis.  During her tenure with FRB, Lisa was a consultant to Boston Market, MGI Pharma, Devon Energy and other Fortune 1000 companies. In 2000, Lisa left to become director of investor Relations for a NYSE-listed REIT, serving in that position until the REIT was acquired. Since then, Lisa has worked as a stock analyst for independent research firms, investment newsletters and financial websites.

Analyst Articles

When one thinks of legendary investors, Peter Lynch stands out as arguably the most successful mutual-fund manager of all time. His track record as manager of Fidelity’s Magellan (Nasdaq: FMAGX) fund is extraordinary. Lynch took control of the Magellan fund in 1977 and grew it into the world’s largest… Read More

When it comes to biotech stocks, some investors like to swing for the fences. When that plan works, it feels great. Shareholders of Dendreon (Nasdaq: DNDN), for example, saw their investment rise from $3 in March 2009 to more than $20 in just two months. The stock has doubled again… Read More

In 1999, James Glassman and Kevin Hassett grabbed headlines with their book Dow 36,000: The New Strategy for Profiting From the Coming Rise in the Stock Market. Their timing was impeccably bad. The Dow Jones Industrial Average peaked later that year at 11,900 and didn’t see the same levels again… Read More